UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID

SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants

By Iqbal Pittalwala | | Health

Building robust collaborations to ‘ATTACK’ future pandemics

As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...

By UCR News | | Health

How sepsis need not be fatal

UC Riverside-led team identifies molecular driver and protector of this life-threatening medical emergency

By Iqbal Pittalwala | | Health

How the South African COVID-19 variant was found

UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain

By Iqbal Pittalwala | | Health

What UC Riverside scientists have to say about vaccines, variants, and antibodies

Immunity generated by vaccination is better than immunity from an actual infection, says an expert

By Iqbal Pittalwala | | Health

Cancer researcher named UCR medical school’s newest endowed chair

Adam Godzik has been named the Bruce D. and Nancy B. Varner Presidential Endowed Chair in Cancer Research

By Iqbal Pittalwala | | Health, University

New drug target found for COVID-19

Scientists discover critical protein complex that lets virus hide from immune system

By UCR News | | Health

New coronavirus protein reveals drug target

Drugs previously in development for SARS could be effective for COVID-19

By UCR News | | Health